The anorexic hormone peptide yy3-36 is rapidly metabolized to inactive peptide yy3-34 in vivo

Physiological Reports

Volumn 3, Issue 7, 2015, Pages

  Toräng, Signe ^a   Veedfald, Simon ^a   Rosenkilde, Mette Marie ^a   Hartmann, Bolette ^a   Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Degradation; Kinetics; Peptide YY

Indexed keywords

NEUROMEDIN C; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY; PEPTIDE YY [3-34]; PEPTIDE YY [3-36]; PHOSPHATIDYLINOSITOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; C TERMINAL DEGRADATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION; DNA TRANSFECTION; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; IN VIVO STUDY; METABOLIC CLEARANCE RATE; METABOLISM; METABOLITE; NONHUMAN; PIG; PLASMA HALF LIFE; RADIOIMMUNOASSAY;

EID: 84958813776     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12455     Document Type: Article

References (21)

1. Aaboe, K., F. K. Knop, T. Vilsbøll, C. F. Deacon, J. J. Holst, S. Madsbad, et al. 2010. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. Diabetes Obes. Metab. 12:323-333.
2. Abbott, C. R., C. J. Small, A. R. Kennedy, N. M. Neary, A. Sajedi, M. A. Ghatei, et al. 1043. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 139-144:2005.
3. Abid, K., B. Rochat, P.-G. Lassahn, R. Stöcklin, S. Michalet, N. Brakch, et al. 2009. Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3-35: a new peptide generated by plasma kallikrein. J. Biol. Chem. 284:24715-24724.
4. Addison, M. L., J. S. Minnion, J. C. Shillito, K. Suzuki, T. M. Tan, B. C. T. Field, et al. 2011. A role for metalloendopeptidases in the breakdown of the gut hormone, PYY3-36. Endocrinology 152:4630-4640.
5. Adrian, T. E., G. L. Ferri, A. J. Bacarese-Hamilton, H. S. Fuessl, J. M. Polak, and S. R. Bloom. 1985. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077.
6. Adrian, T. E., A. J. Bacarese-Hamilton, H. A. Smith, P. Chohan, K. J. Manolas, and S. R. Bloom. 1987. Distribution and postprandial release of porcine peptide YY. J. Endocrinol. 113:11-14.
7. Beckh, K., H. Mönnikes, S. Loos, R. Arnold, and H. Koop. 1992. Low hepatic clearance of peptide YY (PYY) in the perfused rat liver. Regul. Pept. 37:205-212.
8. Beck-Sickinger, A. G., and G. Jung. 1995. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers 37:123-142.
9. Beck-Sickinger, A. G., H. A. Weland, H. Wittneben, K.-D. Willim, K. Rudolf, and G. Jung. 1994. Complete L-Alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur. J. Biochem. 225:947-958.
10. Deacon, C. F., L. Pridal, L. Klarskov, M. Olesen, and J. J. Holst. 1996. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am. J. Physiol. 271:E458-E464.
11. Eberlein, G. A., V. E. Eysselein, M. Schaeffer, P. Layer, D. Grandt, H. Goebell, et al. 1989. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 10:797-803.
12. Glover, I. D., D. J. Barlow, J. E. Pitts, S. P. Wood, I. J. Tickle, T. L. Blundell, et al. 1984. Conformational studies on the pancreatic polypeptide hormone family. Eur. J. Biochem. 142:379-385.
13. Grandt, D., M. Schimiczek, C. Beglinger, P. Layer, H. Goebell, V. E. Eysselein, et al. 1994. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul. Pept. 51:151-159.
14. Hansen, C. P., F. Stadil, and J. F. Rehfeld. 1998. Renal tubular transport and metabolism of carboxyamidated and glycine-extended gastrins in pigs. Acta Physiol. Scand. 164:29-38.
15. Keire, D. A., C. W. Bowers, T. E. Solomon, and J. R. Jr Reeve. 2002. Structure and receptor binding of PYY analogs. Peptides 23:305-321.
16. Khan, I. U., R. Reppich, and A. G. Beck-Sickinger. 2007. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability. Biopolymers 88:182-189.
17. Kissow, H., B. Hartmann, J. J. Holst, N.-E. Viby, L. S. Hansen, M. M. Rosenkilde, et al. 2012. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Regul. Pept. 179:91-100.
18. Link, L., P. Weidmann, P. Probst, and A. Futterlieb. 1985. Renal handling of norepinephrine and epinephrine in the pig. Pflugers Arch. 405:66-69.
19. Medeiros, M. D., and A. J. Turner. 1994. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 134:2088-2094.
20. Rosenkilde, M. M., T. N. Kledal, and T. W. Schwartz. 2005. High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3. Mol. Pharmacol. 68:11-19.
21. Tatemoto, K. 1982. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl Acad. Sci. USA 79:2514-2518.